LY4515100 clinical trials
Also written LY4515100.
How each study uses LY4515100 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the LY4515100 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- LY4515100
- 2
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test LY4515100.
- Nov 2026A Study of LY4515100 in Participants With Pain Following Third Molar RemovalPhase 2 · Eli Lilly and Company
- Dec 2026A Study of LY4515100 in Healthy Male ParticipantsPhase 1 · Eli Lilly and Company
- Mar 2027A Study of LY4515100 in Healthy ParticipantsPhase 1 · Eli Lilly and Company
Studies
Open first, then newest update. How each study uses LY4515100 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study of LY4515100 in Healthy ParticipantsRecruitingPhase 1Eli Lilly and CompanyNCT07339722Written as LY4515100 via SAD
- A Study of LY4515100 in Healthy Male ParticipantsNot yet recruitingPhase 1Eli Lilly and CompanyNCT07867327Written as LY4515100 Tablet
- A Study of LY4515100 in Participants With Pain Following Third Molar RemovalRecruitingPhase 2Eli Lilly and CompanyNCT07511816Written as LY4515100